drugset / Trial / NCT06024499
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which consists of 2 parts.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2026-04-13
- Completion
- 2026-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HY209GEL | Unknown | 0.5 % | — |
| Comparator | HY209GEL | Unknown | 1 % | — |
| Comparator | HY209GEL | Unknown | 2 % | — |
| Comparator | HY209GEL | Unknown | 4 % | — |